Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PYGL | P06737 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6022025 | 0.95 | ALDH1A1 (0.50) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL1819894 | 0.91 | ALDH1A1 (0.67) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL15677508 | 0.89 | ALDH1A1 (0.55) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL9306530 | 0.88 | ALDH1A1 (0.64) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL8633083 | 0.87 | ALDH1A1 (0.53) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL8634636 | 0.87 | MMP1 (0.48) | ALDH1A1HPGDCA12CA9LMNA | |
| SCHEMBL30516910 | 0.87 | ALDH1A1 (0.53) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL8636679 | 0.86 | LMNA (0.50) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL8880053 | 0.86 | ALDH1A1 (0.61) | ALDH1A1HPGDCA12CA2CA9 | |
| SCHEMBL16159995 | 0.84 | ALDH1A1 (0.48) | ALDH1A1HPGDCA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | claimed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | claimed |
| US-9266882-B2 | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications | MEI PHARMA, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150038703-A1 | IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS | HELSINN HEALTHCARE SA (CH) | 2015-02-05 | — | — | US | disclosed |
| EP-1863811-B1 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS | MEI PHARMA INC (US) | 2014-03-12 | — | — | EP | disclosed |
| US-8648092-B2 | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications | MEI Pharma (US) | 2014-02-11 | — | — | US | disclosed |
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038703-A1 | IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS | HDAC1, HDAC2, HDAC5 | ALDH1A1 237/4885HPGD 76/4885CA12 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.